Which has the lower trailing P/E, BIIB or RMD?

RMD has the lower trailing P/E: BIIB trades at 40.06 and RMD at 21.30. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIIB or RMD?

Over the past five years, RMD grew revenue faster — BIIB at a -3.19% CAGR versus RMD at 12.08%.

Does BIIB or RMD pay a bigger dividend?

RMD pays a dividend (1.10% yield), while BIIB has no payments in the available dividend history.

Is BIIB or RMD more profitable?

RMD runs the higher net margin — BIIB at 8.39% versus RMD at 26.94%.

How have BIIB and RMD total returns compared?

Over the past 10 years, BIIB delivered -3.05% and RMD delivered 14.06% annualized total return. Past performance doesn't predict future results.

Biogen Inc. (BIIB) vs ResMed Inc. (RMD)

A side-by-side comparison of Biogen Inc. and ResMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

BIIB

Biogen Inc.

$33.44B

$226.35HealthcareDelayed quote: Sep 24, 2026, 12:10 PM EDT

RMD

ResMed Inc.

$32.13B

$221.50HealthcareDelayed quote: Sep 24, 2026, 12:10 PM EDT

Total return — BIIB vs RMD

growth of $100 · dividends reinvested · last 10y

BIIB -30.5% (-3.6%/yr)RMD +271.7% (+14.0%/yr)RMD compounded faster over this window

Log scale — wide-divergence pair

BIIB RMD

BIIB vs RMD: by the numbers

•BIIB is the larger company ($33.44B vs $32.13B market cap).
•RMD trades at the lower trailing earnings multiple (21.30 vs 40.06 P/E), one valuation lens rather than an overall verdict.
•RMD converts more revenue to profit (26.94% vs 8.39% net margin).
•RMD grew revenue faster over the past five years (12.08% vs -3.19% CAGR).
•RMD pays a dividend (1.10% yield), while BIIB has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BIIB	RMD
P/E ratio	40.06	21.30
Forward P/E	18.23	18.31
P/S ratio	3.36	5.68
P/B ratio	1.77	4.88
EV / EBITDA	N/A	15.06
FCF yield	8.06%	N/A

Profitability

Metric	BIIB	RMD
Gross margin	67.71%	61.16%
Operating margin	12.79%	33.48%
Net margin	8.39%	26.94%
ROE	4.43%	23.13%
ROIC	4.28%	19.18%

Dividends

Metric	BIIB	RMD
Dividend yield	N/A	1.10%
Payout ratio	N/A	23.08%

Growth (annualized)

Metric	BIIB	RMD
Revenue CAGR (5Y)	-3.19%	12.08%
EPS CAGR (5Y)	-18.67%	26.14%
FCF CAGR (5Y)	-11.63%	21.62%
Total return CAGR (5Y)	-6.25%	-5.02%

Frequently asked

Which has the lower trailing P/E, BIIB or RMD?: RMD has the lower trailing P/E: BIIB trades at 40.06 and RMD at 21.30. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIIB or RMD?: Over the past five years, RMD grew revenue faster — BIIB at a -3.19% CAGR versus RMD at 12.08%.
Does BIIB or RMD pay a bigger dividend?: RMD pays a dividend (1.10% yield), while BIIB has no payments in the available dividend history.
Is BIIB or RMD more profitable?: RMD runs the higher net margin — BIIB at 8.39% versus RMD at 26.94%.
How have BIIB and RMD total returns compared?: Over the past 10 years, BIIB delivered -3.05% and RMD delivered 14.06% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIIB analysis Full RMD analysis Interactive comparison tool

Dig into the metrics

Biogen P/E ratio ResMed P/E ratio ResMed dividend yield Biogen ROE ResMed ROE Biogen operating margin ResMed operating margin Biogen revenue growth ResMed revenue growth Biogen free cash flow ResMed free cash flow

Biogen & ResMed appear in these rankings

Highest ROIC Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.